Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Urothelial carcinoma of the bladder in patients on hemodialysis: clinical characteristics and oncological outcomes.

Yossepowitch O, Sagy I, Margel D, Baniel J.

J Urol. 2012 Apr;187(4):1215-9. doi: 10.1016/j.juro.2011.11.098. Epub 2012 Feb 14.

PMID:
22335874
[PubMed - indexed for MEDLINE]
2.

Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.

Kluth LA, Xylinas E, Crivelli JJ, Passoni N, Comploj E, Pycha A, Chrystal J, Sun M, Karakiewicz PI, Gontero P, Lotan Y, Chun FK, Fisch M, Scherr DS, Shariat SF.

J Urol. 2013 Aug;190(2):480-6. doi: 10.1016/j.juro.2013.01.089. Epub 2013 Jan 31.

PMID:
23376707
[PubMed - indexed for MEDLINE]
3.

Diagnosis and management of superficial bladder cancer.

Amling CL.

Curr Probl Cancer. 2001 Jul-Aug;25(4):219-78. Review.

PMID:
11514784
[PubMed - indexed for MEDLINE]
4.

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.

Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T; Cancer Registration Committee of the Japanese Urological Association.

Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.

PMID:
19207609
[PubMed - indexed for MEDLINE]
5.

Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.

Peyromaure M, Guerin F, Amsellem-Ouazana D, Saighi D, Debre B, Zerbib M.

J Urol. 2003 Jun;169(6):2110-2.

PMID:
12771729
[PubMed - indexed for MEDLINE]
6.

Conservative management of low risk superficial bladder tumors.

Pruthi RS, Baldwin N, Bhalani V, Wallen EM.

J Urol. 2008 Jan;179(1):87-90; discussion 90. Epub 2007 Nov 12.

PMID:
17997444
[PubMed - indexed for MEDLINE]
7.

Predicting disease outcome of non-invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: results of patient follow-up for 15 years or longer.

Fujikawa K, Matsui Y, Kobayashi T, Miura K, Oka H, Fukuzawa S, Sasaki M, Takeuchi H, Okabe T.

Int J Urol. 2003 Mar;10(3):149-52.

PMID:
12622711
[PubMed - indexed for MEDLINE]
8.

T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy.

De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V.

Int Urol Nephrol. 2011 Dec;43(4):1047-57. doi: 10.1007/s11255-011-9941-x. Epub 2011 Mar 29.

PMID:
21442469
[PubMed - indexed for MEDLINE]
9.

Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.

Halachmi S, Moskovitz B, Maffezzini M, Conti G, Verweij F, Kedar D, Sandri SD, Nativ O, Colombo R.

Urol Oncol. 2011 May-Jun;29(3):259-64. doi: 10.1016/j.urolonc.2009.02.012. Epub 2009 Apr 22.

PMID:
19395285
[PubMed - indexed for MEDLINE]
10.

Management and prognosis of transitional cell carcinoma superficial recurrence in muscle-invasive bladder cancer after bladder preservation.

Pieras E, Palou J, Salvador J, Rosales A, Marcuello E, Villavicencio H.

Eur Urol. 2003 Aug;44(2):222-5; discussoion 225.

PMID:
12875942
[PubMed - indexed for MEDLINE]
11.
12.

The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.

Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST.

J Urol. 2006 Aug;176(2):477-81.

PMID:
16813872
[PubMed - indexed for MEDLINE]
13.

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.

Zietman AL, Grocela J, Zehr E, Kaufman DS, Young RH, Althausen AF, Heney NM, Shipley WU.

Urology. 2001 Sep;58(3):380-5.

PMID:
11549485
[PubMed - indexed for MEDLINE]
14.

Urothelial carcinoma of the bladder and the upper tract: disparate twins.

Green DA, Rink M, Xylinas E, Matin SF, Stenzl A, Roupret M, Karakiewicz PI, Scherr DS, Shariat SF.

J Urol. 2013 Apr;189(4):1214-21. doi: 10.1016/j.juro.2012.05.079. Epub 2012 Sep 27. Review.

PMID:
23023150
[PubMed - indexed for MEDLINE]
15.

Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.

Solsona E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S.

J Urol. 2002 May;167(5):2007-11.

PMID:
11956428
[PubMed - indexed for MEDLINE]
16.

Percutaneous management of renal pelvic urothelial tumors: long-term followup.

Goel MC, Mahendra V, Roberts JG.

J Urol. 2003 Mar;169(3):925-9; discussion 929-30.

PMID:
12576814
[PubMed - indexed for MEDLINE]
17.

[The intravesical recurrence after 3-day consecutive intravesical instillation of pirarubicine hydrochloride (THP) following transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer].

Tochigi T, Sakurada Y, Aoki H, Kawamura S, Itou S, Satou I, Tateno H.

Nihon Hinyokika Gakkai Zasshi. 2012 Jul;103(4):610-6. Japanese.

PMID:
23120995
[PubMed - indexed for MEDLINE]
18.

Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma.

Wu CF, Shee JJ, Ho DR, Chen WC, Chen CS.

J Urol. 2004 Jan;171(1):126-9.

PMID:
14665859
[PubMed - indexed for MEDLINE]
19.

Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.

Günlüsoy B, Değirmenci T, Arslan M, Nergiz N, Minareci S, Ayder AR.

Urol Int. 2005;75(2):107-13.

PMID:
16123562
[PubMed - indexed for MEDLINE]
20.

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG.

J Clin Oncol. 2001 Feb 1;19(3):666-75.

PMID:
11157016
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk